Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Deanna Johnson

Physician Assistant, Medical Colorado Springs, CO Physician Assistant

NPI 1659309631 CMS profile 10986535

2312 N Nevada Ave Ste 100, Colorado Springs, CO 80907

Open in the dashboard

General payments

$40,916

1,110 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Deanna Johnson of Colorado Springs, CO is reported in the CMS Open Payments database as having received $40,916 across 1,110 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,659 233
2024 General $7,566 215
2023 General $12,493 247
2022 General $4,781 181
2021 General $7,417 234

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Deanna Johnson
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Deanna Johnson were reported at $8,659. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Deanna Johnson Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $7,417 $156 $41–$563 $132
2022 $4,781 $185 $55–$649 $149
2023 $12,493 $199 $58–$717 $160
2024 $7,566 $206 $62–$740 $164
2025 $8,659 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. EMD Serono, Inc. $6,007 96 payments
  2. TG Therapeutics, Inc. $5,576 78 payments
  3. LivaNova USA, Inc. $3,292 22 payments
  4. AbbVie, Inc. $2,435 133 payments
  5. Biogen, Inc. $2,307 78 payments
  6. Abbott Laboratories $2,002 28 payments
  7. Novartis Pharmaceuticals Corporation $1,309 59 payments
  8. Pfizer Inc. $1,229 77 payments
  9. Alexion Pharmaceuticals, Inc. $1,146 36 payments
  10. Boston Scientific Corporation $1,096 9 payments
  11. Other $14,519 494 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $31,477 1,076 payments
  2. Travel and Lodging $4,645 22 payments
  3. Consulting Fee $3,560 4 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,079 4 payments
  5. Education $155 4 payments
Products named General payments · program years 2021–2025
  1. BRIUMVI $5,576 78 payments
  2. VNS Therapy Cardiology/Vascular Diseases $1,657 7 payments
  3. Mavenclad $1,639 11 payments
  4. TYSABRI $1,559 62 payments
  5. UBRELVY $1,476 79 payments
  6. VNS Therapy Neurology $1,191 7 payments
  7. QULIPTA $1,155 60 payments
  8. Infinity DBS Pulse Generators $1,124 11 payments
  9. VUMERITY $1,065 47 payments
  10. OXTELLAR XR $1,059 9 payments
  11. Other $21,777 839 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 49 drugs

Part D claims

1,885

Median for Physician Assistant: 241

Drug cost

$1,287,738

Median for Physician Assistant: $4,110

Branded share of claims

36.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Kesimpta Pen Ofatumumab Brand 55 $552,996
Epidiolex Cannabidiol (Cbd) Brand 14 $133,460
Avonex (4 Pack) Interferon Beta-1a Brand 13 $124,659
Aubagio Teriflunomide Brand 11 $100,473
Aimovig Autoinjector Erenumab-Aooe Brand 44 $44,879
Dalfampridine Er Dalfampridine Brand 64 $39,325
Ajovy Autoinjector Fremanezumab-Vfrm Brand 43 $39,263
Xcopri Cenobamate Brand 31 $38,373
Fycompa Perampanel Brand 29 $36,316
Nurtec Odt Rimegepant Sulfate Brand 27 $31,950

The 10 drugs with the highest cost, of 49 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$41,382

Medicare's payments for the services billed

Medicare patients

211

Average age 69

Services billed

3,426

121 women, 90 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 57%
Arthritis 43%
Depression 28%
Diabetes 24%
Ischemic heart disease 23%
Chronic kidney disease 23%
COPD 16%
Alzheimer's or dementia 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 48 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BRIUMVI
$692 — —
KESIMPTA
$286 55 —
UBRELVY
$242 23 —
XYWAV
$222 — —
ULTOMIRIS
$205 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 48 with Patron

Records

1,110 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record